AEON Biopharma ( (AEON) ) just unveiled an announcement.
On March 10, 2025, AEON Biopharma made available a Corporate Presentation in the investor relations section of its website, which may be utilized by the company’s management in future meetings. This presentation is not considered filed under the Securities Exchange Act of 1934, and its information is not subject to the liabilities of that section.
More about AEON Biopharma
AEON Biopharma, Inc. operates in the biopharmaceutical industry, focusing on developing therapeutic treatments for debilitating medical conditions.
YTD Price Performance: -98.30%
Average Trading Volume: 1,954,217
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $733.2K
Find detailed analytics on AEON stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com